{"id": "F1.1-000001", "family_id": "F1.1", "template_id": "f1_1_targets_gene", "question": "What drugs target PSMD12?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PSMD12')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PSMD12'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 50\n", "result": [{"therapy_name": "Bortezomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "21606441"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "http://europepmc.org/abstract/MED/21606441"]}, {"therapy_name": "Carfilzomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2012/202714lbl.pdf", "20116451"], "ref_urls": ["http://europepmc.org/abstract/MED/20116451", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf"]}, {"therapy_name": "Ixazomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteasome inhibitor", "ref_sources": ["EMA", "PubMed", "PubMed"], "ref_ids": ["https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf", "23995855", "30867233"], "ref_urls": ["http://europepmc.org/abstract/MED/23995855", "http://europepmc.org/abstract/MED/30867233", "https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf"]}], "error": null}
{"id": "F1.1-000001-P1", "family_id": "F1.1", "template_id": "f1_1_targets_gene", "question": "Which therapies target PSMD12?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PSMD12')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PSMD12'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 50\n", "result": [{"therapy_name": "Bortezomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "21606441"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "http://europepmc.org/abstract/MED/21606441"]}, {"therapy_name": "Carfilzomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2012/202714lbl.pdf", "20116451"], "ref_urls": ["http://europepmc.org/abstract/MED/20116451", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf"]}, {"therapy_name": "Ixazomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteasome inhibitor", "ref_sources": ["EMA", "PubMed", "PubMed"], "ref_ids": ["https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf", "23995855", "30867233"], "ref_urls": ["http://europepmc.org/abstract/MED/23995855", "http://europepmc.org/abstract/MED/30867233", "https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf"]}], "error": null}
{"id": "F1.1-000001-P2", "family_id": "F1.1", "template_id": "f1_1_targets_gene", "question": "List treatments that target PSMD12.", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PSMD12')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PSMD12'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 50\n", "result": [{"therapy_name": "Bortezomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "21606441"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "http://europepmc.org/abstract/MED/21606441"]}, {"therapy_name": "Carfilzomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2012/202714lbl.pdf", "20116451"], "ref_urls": ["http://europepmc.org/abstract/MED/20116451", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf"]}, {"therapy_name": "Ixazomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteasome inhibitor", "ref_sources": ["EMA", "PubMed", "PubMed"], "ref_ids": ["https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf", "23995855", "30867233"], "ref_urls": ["http://europepmc.org/abstract/MED/23995855", "http://europepmc.org/abstract/MED/30867233", "https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf"]}], "error": null}
{"id": "F1.1-000001-P3", "family_id": "F1.1", "template_id": "f1_1_targets_gene", "question": "What medications are known to target PSMD12?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PSMD12')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PSMD12'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 50\n", "result": [{"therapy_name": "Bortezomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "21606441"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "http://europepmc.org/abstract/MED/21606441"]}, {"therapy_name": "Carfilzomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2012/202714lbl.pdf", "20116451"], "ref_urls": ["http://europepmc.org/abstract/MED/20116451", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf"]}, {"therapy_name": "Ixazomib", "gene_symbol": "PSMD12", "targets_moa": "26S proteasome inhibitor", "ref_sources": ["EMA", "PubMed", "PubMed"], "ref_ids": ["https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf", "23995855", "30867233"], "ref_urls": ["http://europepmc.org/abstract/MED/23995855", "http://europepmc.org/abstract/MED/30867233", "https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf"]}], "error": null}
{"id": "F1.2-000001", "family_id": "F1.2", "template_id": "f1_2_genes_for_therapy", "question": "Which genes does BRAF Inhibitor target?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('BRAF Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('BRAF Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('BRAF Inhibitor')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 50\n", "result": [{"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}], "error": null}
{"id": "F1.2-000001-P1", "family_id": "F1.2", "template_id": "f1_2_genes_for_therapy", "question": "What genes does BRAF Inhibitor target?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('BRAF Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('BRAF Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('BRAF Inhibitor')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 50\n", "result": [{"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}], "error": null}
{"id": "F1.2-000001-P2", "family_id": "F1.2", "template_id": "f1_2_genes_for_therapy", "question": "List genes that BRAF Inhibitor targets.", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('BRAF Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('BRAF Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('BRAF Inhibitor')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 50\n", "result": [{"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}], "error": null}
{"id": "F1.2-000001-P3", "family_id": "F1.2", "template_id": "f1_2_genes_for_therapy", "question": "Which genes are targeted by BRAF Inhibitor?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('BRAF Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('BRAF Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('BRAF Inhibitor')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 50\n", "result": [{"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}], "error": null}
{"id": "F1.3-000001", "family_id": "F1.3", "template_id": "f1_3_gene_of_variant", "question": "Which gene is BRAF V600E a variant of?", "cypher": "MATCH (v:Variant {name: 'BRAF V600E'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 50\n", "result": [{"gene_symbol": "BRAF", "variant_name": "BRAF V600E"}], "error": null}
{"id": "F1.3-000001-P1", "family_id": "F1.3", "template_id": "f1_3_gene_of_variant", "question": "BRAF V600E belongs to which gene?", "cypher": "MATCH (v:Variant {name: 'BRAF V600E'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 50\n", "result": [{"gene_symbol": "BRAF", "variant_name": "BRAF V600E"}], "error": null}
{"id": "F1.3-000001-P2", "family_id": "F1.3", "template_id": "f1_3_gene_of_variant", "question": "BRAF V600E is a variant of what gene?", "cypher": "MATCH (v:Variant {name: 'BRAF V600E'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 50\n", "result": [{"gene_symbol": "BRAF", "variant_name": "BRAF V600E"}], "error": null}
{"id": "F1.3-000001-P3", "family_id": "F1.3", "template_id": "f1_3_gene_of_variant", "question": "Identify the gene for the variant BRAF V600E.", "cypher": "MATCH (v:Variant {name: 'BRAF V600E'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 50\n", "result": [{"gene_symbol": "BRAF", "variant_name": "BRAF V600E"}], "error": null}
{"id": "F1.4-000001", "family_id": "F1.4", "template_id": "f1_4_variants_of_gene", "question": "List all known variants of the RARG gene.", "cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('RARG')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('RARG'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 50\n", "result": [], "error": null}
{"id": "F1.4-000001-P1", "family_id": "F1.4", "template_id": "f1_4_variants_of_gene", "question": "What variants are known for the RARG gene?", "cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('RARG')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('RARG'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 50\n", "result": [], "error": null}
{"id": "F1.4-000001-P2", "family_id": "F1.4", "template_id": "f1_4_variants_of_gene", "question": "Show the variants associated with RARG.", "cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('RARG')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('RARG'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 50\n", "result": [], "error": null}
{"id": "F1.4-000001-P3", "family_id": "F1.4", "template_id": "f1_4_variants_of_gene", "question": "Which variants belong to the gene RARG?", "cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('RARG')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('RARG'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 50\n", "result": [], "error": null}
{"id": "F2.1-000001", "family_id": "F2.1", "template_id": "f2_1_targets_properties", "question": "What is Valproic Acid's mechanism of action on ALDH5A1?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Valproic Acid')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Valproic Acid'))\n  OR toLower(t.name) CONTAINS toLower('Valproic Acid')\n)\n  AND (\n    toLower(g.symbol) = toLower('ALDH5A1')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALDH5A1'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "ALDH5A1", "therapy_name": "Valproic Acid", "targets_moa": "Succinate semialdehyde dehydrogenase inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["10812195"], "ref_urls": ["http://europepmc.org/abstract/MED/10812195"]}], "error": null}
{"id": "F2.1-000001-P1", "family_id": "F2.1", "template_id": "f2_1_targets_properties", "question": "What is the MOA of Valproic Acid on ALDH5A1?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Valproic Acid')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Valproic Acid'))\n  OR toLower(t.name) CONTAINS toLower('Valproic Acid')\n)\n  AND (\n    toLower(g.symbol) = toLower('ALDH5A1')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALDH5A1'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "ALDH5A1", "therapy_name": "Valproic Acid", "targets_moa": "Succinate semialdehyde dehydrogenase inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["10812195"], "ref_urls": ["http://europepmc.org/abstract/MED/10812195"]}], "error": null}
{"id": "F2.1-000001-P2", "family_id": "F2.1", "template_id": "f2_1_targets_properties", "question": "Describe how Valproic Acid acts on ALDH5A1.", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Valproic Acid')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Valproic Acid'))\n  OR toLower(t.name) CONTAINS toLower('Valproic Acid')\n)\n  AND (\n    toLower(g.symbol) = toLower('ALDH5A1')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALDH5A1'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "ALDH5A1", "therapy_name": "Valproic Acid", "targets_moa": "Succinate semialdehyde dehydrogenase inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["10812195"], "ref_urls": ["http://europepmc.org/abstract/MED/10812195"]}], "error": null}
{"id": "F2.1-000001-P3", "family_id": "F2.1", "template_id": "f2_1_targets_properties", "question": "What is Valproic Acid's mechanism against ALDH5A1?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Valproic Acid')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Valproic Acid'))\n  OR toLower(t.name) CONTAINS toLower('Valproic Acid')\n)\n  AND (\n    toLower(g.symbol) = toLower('ALDH5A1')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALDH5A1'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "ALDH5A1", "therapy_name": "Valproic Acid", "targets_moa": "Succinate semialdehyde dehydrogenase inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["10812195"], "ref_urls": ["http://europepmc.org/abstract/MED/10812195"]}], "error": null}
{"id": "F2.2-000001", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease", "question": "Which genes affect response to Immune Checkpoint Inhibitor in Lung Non-small Cell Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Immune Checkpoint Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Immune Checkpoint Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('Immune Checkpoint Inhibitor')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Immune Checkpoint Inhibitor", "effect": null, "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28259530"]}], "error": null}
{"id": "F2.2-000001-P1", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease", "question": "What genes are predictive biomarkers for Immune Checkpoint Inhibitor in Lung Non-small Cell Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Immune Checkpoint Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Immune Checkpoint Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('Immune Checkpoint Inhibitor')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Immune Checkpoint Inhibitor", "effect": null, "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28259530"]}], "error": null}
{"id": "F2.2-000001-P2", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease", "question": "Which genes influence response to Immune Checkpoint Inhibitor for Lung Non-small Cell Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Immune Checkpoint Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Immune Checkpoint Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('Immune Checkpoint Inhibitor')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Immune Checkpoint Inhibitor", "effect": null, "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28259530"]}], "error": null}
{"id": "F2.2-000001-P3", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease", "question": "List genes with evidence affecting Immune Checkpoint Inhibitor in Lung Non-small Cell Carcinoma.", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Immune Checkpoint Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Immune Checkpoint Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('Immune Checkpoint Inhibitor')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Immune Checkpoint Inhibitor", "effect": null, "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28259530"]}], "error": null}
{"id": "F2.2-000001", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease_resistance", "question": "Which genes predict resistance to Entrectinib in Mammary Analogue Secretory Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Entrectinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Entrectinib'))\n  OR toLower(t.name) CONTAINS toLower('Entrectinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'mammary' AND\n    toLower(rel.disease_name) CONTAINS 'analogue' AND\n    toLower(rel.disease_name) CONTAINS 'secretory' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "resistance", "disease_name": "Mammary Analogue Secretory Carcinoma", "pmids": ["26884591"]}], "error": null}
{"id": "F2.2-000001-P1", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease_resistance", "question": "Which genes confer resistance to Entrectinib in Mammary Analogue Secretory Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Entrectinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Entrectinib'))\n  OR toLower(t.name) CONTAINS toLower('Entrectinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'mammary' AND\n    toLower(rel.disease_name) CONTAINS 'analogue' AND\n    toLower(rel.disease_name) CONTAINS 'secretory' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "resistance", "disease_name": "Mammary Analogue Secretory Carcinoma", "pmids": ["26884591"]}], "error": null}
{"id": "F2.2-000001-P2", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease_resistance", "question": "List genes associated with resistance to Entrectinib in Mammary Analogue Secretory Carcinoma.", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Entrectinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Entrectinib'))\n  OR toLower(t.name) CONTAINS toLower('Entrectinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'mammary' AND\n    toLower(rel.disease_name) CONTAINS 'analogue' AND\n    toLower(rel.disease_name) CONTAINS 'secretory' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "resistance", "disease_name": "Mammary Analogue Secretory Carcinoma", "pmids": ["26884591"]}], "error": null}
{"id": "F2.2-000001-P3", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease_resistance", "question": "What genes are resistance biomarkers for Entrectinib in Mammary Analogue Secretory Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Entrectinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Entrectinib'))\n  OR toLower(t.name) CONTAINS toLower('Entrectinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'mammary' AND\n    toLower(rel.disease_name) CONTAINS 'analogue' AND\n    toLower(rel.disease_name) CONTAINS 'secretory' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "resistance", "disease_name": "Mammary Analogue Secretory Carcinoma", "pmids": ["26884591"]}], "error": null}
{"id": "F2.2-000001", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease_sensitivity", "question": "Which genes predict sensitivity to C646 in Lung Non-small Cell Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('C646')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('C646'))\n  OR toLower(t.name) CONTAINS toLower('C646')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "CREBBP", "therapy_name": "C646", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26603525"]}], "error": null}
{"id": "F2.2-000001-P1", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease_sensitivity", "question": "Which genes confer sensitivity to C646 in Lung Non-small Cell Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('C646')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('C646'))\n  OR toLower(t.name) CONTAINS toLower('C646')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "CREBBP", "therapy_name": "C646", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26603525"]}], "error": null}
{"id": "F2.2-000001-P2", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease_sensitivity", "question": "List genes associated with sensitivity to C646 in Lung Non-small Cell Carcinoma.", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('C646')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('C646'))\n  OR toLower(t.name) CONTAINS toLower('C646')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "CREBBP", "therapy_name": "C646", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26603525"]}], "error": null}
{"id": "F2.2-000001-P3", "family_id": "F2.2", "template_id": "f2_2_gene_affects_therapy_disease_sensitivity", "question": "What genes are sensitivity biomarkers for C646 in Lung Non-small Cell Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('C646')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('C646'))\n  OR toLower(t.name) CONTAINS toLower('C646')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "CREBBP", "therapy_name": "C646", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26603525"]}], "error": null}
{"id": "F2.2-000001", "family_id": "F2.2", "template_id": "f2_2_variant_affects_therapy_disease", "question": "How does the variant PIK3CA Mutation affect response to Trastuzumab in Breast Cancer?", "cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Trastuzumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Trastuzumab'))\n  OR toLower(t.name) CONTAINS toLower('Trastuzumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["21594665"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab", "effect": "resistance", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["21594665", "17936563"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab Emtansine", "effect": "resistance", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["26920887"]}], "error": null}
{"id": "F2.2-000001-P1", "family_id": "F2.2", "template_id": "f2_2_variant_affects_therapy_disease", "question": "What is the effect of PIK3CA Mutation on Trastuzumab in Breast Cancer?", "cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Trastuzumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Trastuzumab'))\n  OR toLower(t.name) CONTAINS toLower('Trastuzumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["21594665"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab", "effect": "resistance", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["21594665", "17936563"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab Emtansine", "effect": "resistance", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["26920887"]}], "error": null}
{"id": "F2.2-000001-P2", "family_id": "F2.2", "template_id": "f2_2_variant_affects_therapy_disease", "question": "Does PIK3CA Mutation predict response to Trastuzumab in Breast Cancer?", "cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Trastuzumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Trastuzumab'))\n  OR toLower(t.name) CONTAINS toLower('Trastuzumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["21594665"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab", "effect": "resistance", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["21594665", "17936563"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab Emtansine", "effect": "resistance", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["26920887"]}], "error": null}
{"id": "F2.2-000001-P3", "family_id": "F2.2", "template_id": "f2_2_variant_affects_therapy_disease", "question": "How does PIK3CA Mutation influence response to Trastuzumab for Breast Cancer?", "cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Trastuzumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Trastuzumab'))\n  OR toLower(t.name) CONTAINS toLower('Trastuzumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["21594665"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab", "effect": "resistance", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["21594665", "17936563"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Trastuzumab Emtansine", "effect": "resistance", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["26920887"]}], "error": null}
{"id": "F2.2-000001", "family_id": "F2.2", "template_id": "f2_2_variant_token_affects_therapy_disease", "question": "How does the variant ERBB2 L755S affect response to Capecitabine in Triple-receptor Negative Breast Cancer?", "cypher": "MATCH (v:Variant {name: 'ERBB2 L755S'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Capecitabine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Capecitabine'))\n  OR toLower(t.name) CONTAINS toLower('Capecitabine')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'triple-receptor' AND\n    toLower(rel.disease_name) CONTAINS 'negative' AND\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB2 L755S", "gene_symbol": "ERBB2", "therapy_name": "Capecitabine", "effect": "sensitivity", "disease_name": "Triple-receptor Negative Breast Cancer", "pmids": ["26358790"]}], "error": null}
{"id": "F2.2-000001-P1", "family_id": "F2.2", "template_id": "f2_2_variant_token_affects_therapy_disease", "question": "What is the effect of ERBB2 L755S on Capecitabine in Triple-receptor Negative Breast Cancer?", "cypher": "MATCH (v:Variant {name: 'ERBB2 L755S'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Capecitabine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Capecitabine'))\n  OR toLower(t.name) CONTAINS toLower('Capecitabine')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'triple-receptor' AND\n    toLower(rel.disease_name) CONTAINS 'negative' AND\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB2 L755S", "gene_symbol": "ERBB2", "therapy_name": "Capecitabine", "effect": "sensitivity", "disease_name": "Triple-receptor Negative Breast Cancer", "pmids": ["26358790"]}], "error": null}
{"id": "F2.2-000001-P2", "family_id": "F2.2", "template_id": "f2_2_variant_token_affects_therapy_disease", "question": "Does ERBB2 L755S predict response to Capecitabine in Triple-receptor Negative Breast Cancer?", "cypher": "MATCH (v:Variant {name: 'ERBB2 L755S'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Capecitabine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Capecitabine'))\n  OR toLower(t.name) CONTAINS toLower('Capecitabine')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'triple-receptor' AND\n    toLower(rel.disease_name) CONTAINS 'negative' AND\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB2 L755S", "gene_symbol": "ERBB2", "therapy_name": "Capecitabine", "effect": "sensitivity", "disease_name": "Triple-receptor Negative Breast Cancer", "pmids": ["26358790"]}], "error": null}
{"id": "F2.2-000001-P3", "family_id": "F2.2", "template_id": "f2_2_variant_token_affects_therapy_disease", "question": "How does ERBB2 L755S influence response to Capecitabine for Triple-receptor Negative Breast Cancer?", "cypher": "MATCH (v:Variant {name: 'ERBB2 L755S'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Capecitabine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Capecitabine'))\n  OR toLower(t.name) CONTAINS toLower('Capecitabine')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'triple-receptor' AND\n    toLower(rel.disease_name) CONTAINS 'negative' AND\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB2 L755S", "gene_symbol": "ERBB2", "therapy_name": "Capecitabine", "effect": "sensitivity", "disease_name": "Triple-receptor Negative Breast Cancer", "pmids": ["26358790"]}], "error": null}
{"id": "F2.3-000001", "family_id": "F2.3", "template_id": "f2_3_evidential_pmids_variant_resistance", "question": "Provide PMIDs supporting that RB1 Loss-of-function confers resistance to Palbociclib.", "cypher": "MATCH (v:Variant {name: 'RB1 Loss-of-function'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Palbociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Palbociclib'))\n  OR toLower(t.name) CONTAINS toLower('Palbociclib')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["20473330"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["20354191"]}], "error": null}
{"id": "F2.3-000001-P1", "family_id": "F2.3", "template_id": "f2_3_evidential_pmids_variant_resistance", "question": "Cite PubMed IDs showing RB1 Loss-of-function causes resistance to Palbociclib.", "cypher": "MATCH (v:Variant {name: 'RB1 Loss-of-function'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Palbociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Palbociclib'))\n  OR toLower(t.name) CONTAINS toLower('Palbociclib')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["20473330"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["20354191"]}], "error": null}
{"id": "F2.3-000001-P2", "family_id": "F2.3", "template_id": "f2_3_evidential_pmids_variant_resistance", "question": "What PMIDs support resistance of Palbociclib due to RB1 Loss-of-function?", "cypher": "MATCH (v:Variant {name: 'RB1 Loss-of-function'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Palbociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Palbociclib'))\n  OR toLower(t.name) CONTAINS toLower('Palbociclib')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["20473330"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["20354191"]}], "error": null}
{"id": "F2.3-000001-P3", "family_id": "F2.3", "template_id": "f2_3_evidential_pmids_variant_resistance", "question": "Give PMIDs for RB1 Loss-of-function-mediated resistance to Palbociclib.", "cypher": "MATCH (v:Variant {name: 'RB1 Loss-of-function'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Palbociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Palbociclib'))\n  OR toLower(t.name) CONTAINS toLower('Palbociclib')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Breast Cancer", "pmids": ["20473330"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["20354191"]}], "error": null}
{"id": "F2.3-000001", "family_id": "F2.3", "template_id": "f2_3_evidential_pmids_variant_sensitivity", "question": "Provide PMIDs supporting that ERBB3 Overexpression confers sensitivity to Selumetinib.", "cypher": "MATCH (v:Variant {name: 'ERBB3 Overexpression'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Selumetinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Selumetinib'))\n  OR toLower(t.name) CONTAINS toLower('Selumetinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB3 Overexpression", "gene_symbol": "ERBB3", "therapy_name": "Selumetinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["24685132"]}], "error": null}
{"id": "F2.3-000001-P1", "family_id": "F2.3", "template_id": "f2_3_evidential_pmids_variant_sensitivity", "question": "Cite PMIDs showing ERBB3 Overexpression predicts sensitivity to Selumetinib.", "cypher": "MATCH (v:Variant {name: 'ERBB3 Overexpression'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Selumetinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Selumetinib'))\n  OR toLower(t.name) CONTAINS toLower('Selumetinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB3 Overexpression", "gene_symbol": "ERBB3", "therapy_name": "Selumetinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["24685132"]}], "error": null}
{"id": "F2.3-000001-P2", "family_id": "F2.3", "template_id": "f2_3_evidential_pmids_variant_sensitivity", "question": "What PubMed IDs support sensitivity of Selumetinib due to ERBB3 Overexpression?", "cypher": "MATCH (v:Variant {name: 'ERBB3 Overexpression'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Selumetinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Selumetinib'))\n  OR toLower(t.name) CONTAINS toLower('Selumetinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB3 Overexpression", "gene_symbol": "ERBB3", "therapy_name": "Selumetinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["24685132"]}], "error": null}
{"id": "F2.3-000001-P3", "family_id": "F2.3", "template_id": "f2_3_evidential_pmids_variant_sensitivity", "question": "Give PMIDs for ERBB3 Overexpression-mediated sensitivity to Selumetinib.", "cypher": "MATCH (v:Variant {name: 'ERBB3 Overexpression'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Selumetinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Selumetinib'))\n  OR toLower(t.name) CONTAINS toLower('Selumetinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB3 Overexpression", "gene_symbol": "ERBB3", "therapy_name": "Selumetinib", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["24685132"]}], "error": null}
{"id": "F2.4-000001", "family_id": "F2.4", "template_id": "f2_4_variant_node_property", "question": "What is the consequence of the BRAF V600E variant?", "cypher": "MATCH (v:Variant {name: 'BRAF V600E'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 50\n", "result": [{"variant_name": "BRAF V600E", "variant_consequence": null}], "error": null}
{"id": "F2.4-000001-P1", "family_id": "F2.4", "template_id": "f2_4_variant_node_property", "question": "What consequence does the variant BRAF V600E have?", "cypher": "MATCH (v:Variant {name: 'BRAF V600E'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 50\n", "result": [{"variant_name": "BRAF V600E", "variant_consequence": null}], "error": null}
{"id": "F2.4-000001-P2", "family_id": "F2.4", "template_id": "f2_4_variant_node_property", "question": "Report the consequence for BRAF V600E.", "cypher": "MATCH (v:Variant {name: 'BRAF V600E'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 50\n", "result": [{"variant_name": "BRAF V600E", "variant_consequence": null}], "error": null}
{"id": "F2.4-000001-P3", "family_id": "F2.4", "template_id": "f2_4_variant_node_property", "question": "What is the functional consequence of BRAF V600E?", "cypher": "MATCH (v:Variant {name: 'BRAF V600E'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 50\n", "result": [{"variant_name": "BRAF V600E", "variant_consequence": null}], "error": null}
{"id": "F3.1-000001", "family_id": "F3.1", "template_id": "f3_1_therapies_union_genes", "question": "Find therapies for ABL1 or ADRM1.", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(g.symbol) = toLower('ABL1')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ABL1'))\n  OR toLower(g.symbol) = toLower('ADRM1')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ADRM1'))\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "ABL1", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["FDA", "Other", "Other"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf", "http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML"], "ref_urls": ["http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Bafetinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16105974"], "ref_urls": ["http://europepmc.org/abstract/MED/16105974"]}, {"gene_symbol": "ABL1", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["BOSUTINIB", "label/2012/203341lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=BOSUTINIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "ABL1", "therapy_name": "Rebastinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["21481795"], "ref_urls": ["http://europepmc.org/abstract/MED/21481795"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "TRK Inhibitor", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ADRM1", "therapy_name": "Bortezomib", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "21606441"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "http://europepmc.org/abstract/MED/21606441"]}, {"gene_symbol": "ADRM1", "therapy_name": "Carfilzomib", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2012/202714lbl.pdf", "20116451"], "ref_urls": ["http://europepmc.org/abstract/MED/20116451", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf"]}, {"gene_symbol": "ADRM1", "therapy_name": "Ixazomib", "targets_moa": "26S proteasome inhibitor", "ref_sources": ["EMA", "PubMed", "PubMed"], "ref_ids": ["https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf", "23995855", "30867233"], "ref_urls": ["http://europepmc.org/abstract/MED/23995855", "http://europepmc.org/abstract/MED/30867233", "https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf"]}], "error": null}
{"id": "F3.1-000001-P1", "family_id": "F3.1", "template_id": "f3_1_therapies_union_genes", "question": "Which therapies target ABL1 or ADRM1?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(g.symbol) = toLower('ABL1')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ABL1'))\n  OR toLower(g.symbol) = toLower('ADRM1')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ADRM1'))\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "ABL1", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["FDA", "Other", "Other"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf", "http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML"], "ref_urls": ["http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Bafetinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16105974"], "ref_urls": ["http://europepmc.org/abstract/MED/16105974"]}, {"gene_symbol": "ABL1", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["BOSUTINIB", "label/2012/203341lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=BOSUTINIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "ABL1", "therapy_name": "Rebastinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["21481795"], "ref_urls": ["http://europepmc.org/abstract/MED/21481795"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "TRK Inhibitor", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ADRM1", "therapy_name": "Bortezomib", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "21606441"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "http://europepmc.org/abstract/MED/21606441"]}, {"gene_symbol": "ADRM1", "therapy_name": "Carfilzomib", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2012/202714lbl.pdf", "20116451"], "ref_urls": ["http://europepmc.org/abstract/MED/20116451", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf"]}, {"gene_symbol": "ADRM1", "therapy_name": "Ixazomib", "targets_moa": "26S proteasome inhibitor", "ref_sources": ["EMA", "PubMed", "PubMed"], "ref_ids": ["https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf", "23995855", "30867233"], "ref_urls": ["http://europepmc.org/abstract/MED/23995855", "http://europepmc.org/abstract/MED/30867233", "https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf"]}], "error": null}
{"id": "F3.1-000001-P2", "family_id": "F3.1", "template_id": "f3_1_therapies_union_genes", "question": "List drugs for ABL1 or ADRM1.", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(g.symbol) = toLower('ABL1')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ABL1'))\n  OR toLower(g.symbol) = toLower('ADRM1')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ADRM1'))\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "ABL1", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["FDA", "Other", "Other"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf", "http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML"], "ref_urls": ["http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Bafetinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16105974"], "ref_urls": ["http://europepmc.org/abstract/MED/16105974"]}, {"gene_symbol": "ABL1", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["BOSUTINIB", "label/2012/203341lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=BOSUTINIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "ABL1", "therapy_name": "Rebastinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["21481795"], "ref_urls": ["http://europepmc.org/abstract/MED/21481795"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "TRK Inhibitor", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ADRM1", "therapy_name": "Bortezomib", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "21606441"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "http://europepmc.org/abstract/MED/21606441"]}, {"gene_symbol": "ADRM1", "therapy_name": "Carfilzomib", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2012/202714lbl.pdf", "20116451"], "ref_urls": ["http://europepmc.org/abstract/MED/20116451", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf"]}, {"gene_symbol": "ADRM1", "therapy_name": "Ixazomib", "targets_moa": "26S proteasome inhibitor", "ref_sources": ["EMA", "PubMed", "PubMed"], "ref_ids": ["https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf", "23995855", "30867233"], "ref_urls": ["http://europepmc.org/abstract/MED/23995855", "http://europepmc.org/abstract/MED/30867233", "https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf"]}], "error": null}
{"id": "F3.1-000001-P3", "family_id": "F3.1", "template_id": "f3_1_therapies_union_genes", "question": "Show treatments that target ABL1 or ADRM1.", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(g.symbol) = toLower('ABL1')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ABL1'))\n  OR toLower(g.symbol) = toLower('ADRM1')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ADRM1'))\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "ABL1", "therapy_name": "Asciminib", "targets_moa": "Bcr/Abl fusion protein inhibitor | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["FDA", "Other", "Other"], "ref_ids": ["label/2021/215358s000Orig1lbl.pdf", "http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML"], "ref_urls": ["http://www.bloodjournal.org/content/124/21/398?sso-checked=true", "http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig1lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Bafetinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16105974"], "ref_urls": ["http://europepmc.org/abstract/MED/16105974"]}, {"gene_symbol": "ABL1", "therapy_name": "Bosutinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["BOSUTINIB", "label/2012/203341lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=BOSUTINIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203341lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Dasatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Imatinib Mesylate", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Nilotinib", "targets_moa": "Bcr/Abl fusion protein | Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "label/2010/022068s004s005lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022068s004s005lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Ponatinib", "targets_moa": "Bcr/Abl fusion protein inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=807f988e-117b-4497-934d-73aa78baac71", "19878872"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807f988e-117b-4497-934d-73aa78baac71", "http://europepmc.org/abstract/MED/19878872"]}, {"gene_symbol": "ABL1", "therapy_name": "Rebastinib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["21481795"], "ref_urls": ["http://europepmc.org/abstract/MED/21481795"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ABL1", "therapy_name": "TRK Inhibitor", "targets_moa": "Tyrosine-protein kinase ABL inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "ADRM1", "therapy_name": "Bortezomib", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "21606441"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13", "http://europepmc.org/abstract/MED/21606441"]}, {"gene_symbol": "ADRM1", "therapy_name": "Carfilzomib", "targets_moa": "26S proteosome inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2012/202714lbl.pdf", "20116451"], "ref_urls": ["http://europepmc.org/abstract/MED/20116451", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202714lbl.pdf"]}, {"gene_symbol": "ADRM1", "therapy_name": "Ixazomib", "targets_moa": "26S proteasome inhibitor", "ref_sources": ["EMA", "PubMed", "PubMed"], "ref_ids": ["https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf", "23995855", "30867233"], "ref_urls": ["http://europepmc.org/abstract/MED/23995855", "http://europepmc.org/abstract/MED/30867233", "https://www.ema.europa.eu/en/documents/assessment-report/ninlaro-epar-public-assessment-report_en.pdf"]}], "error": null}
{"id": "F3.2-000001", "family_id": "F3.2", "template_id": "f3_2_therapies_intersection_genes", "question": "What therapies target both TOP1 and ERBB2?", "cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('ERBB2')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('ERBB2'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "error": null}
{"id": "F3.2-000001-P1", "family_id": "F3.2", "template_id": "f3_2_therapies_intersection_genes", "question": "Which drugs target both TOP1 and ERBB2?", "cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('ERBB2')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('ERBB2'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "error": null}
{"id": "F3.2-000001-P2", "family_id": "F3.2", "template_id": "f3_2_therapies_intersection_genes", "question": "List therapies that hit TOP1 and ERBB2.", "cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('ERBB2')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('ERBB2'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "error": null}
{"id": "F3.2-000001-P3", "family_id": "F3.2", "template_id": "f3_2_therapies_intersection_genes", "question": "Show treatments targeting both TOP1 and ERBB2.", "cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('ERBB2')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('ERBB2'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "error": null}
{"id": "F3.3-000001", "family_id": "F3.3", "template_id": "f3_3_therapies_target_a_not_b", "question": "Which drugs target TOP1 but not ALK?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('ALK')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "error": null}
{"id": "F3.3-000001-P1", "family_id": "F3.3", "template_id": "f3_3_therapies_target_a_not_b", "question": "What therapies hit TOP1 but exclude ALK?", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('ALK')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "error": null}
{"id": "F3.3-000001-P2", "family_id": "F3.3", "template_id": "f3_3_therapies_target_a_not_b", "question": "List treatments targeting TOP1 and not ALK.", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('ALK')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "error": null}
{"id": "F3.3-000001-P3", "family_id": "F3.3", "template_id": "f3_3_therapies_target_a_not_b", "question": "Show therapies for TOP1 but not for ALK.", "cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('ALK')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "error": null}
{"id": "F4.1-000001", "family_id": "F4.1", "template_id": "f4_1_target_validation_gene_disease", "question": "Which therapies target TOP1 and also have biomarker evidence in Colorectal Cancer?", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "SLFN11 EXPRESSION", "gene_symbol": "SLFN11", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25089570"]}, {"variant_name": "BRAF D594G", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "BRAF D594K", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF G466V", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["28783719"]}, {"variant_name": "BRAF Mutation", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF V600", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["147167"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024", "19603018"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27729313", "22180495"]}, {"variant_name": "BRAF V600E AND ARAF S490T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND GNAS R201C", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 C121S", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 K57T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "DKK1 NUCLEAR EXPRESSION", "gene_symbol": "DKK1", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25788273"]}, {"variant_name": "KRAS A146P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603018"]}, {"variant_name": "KRAS A146T", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "KRAS Exon 2 Mutation", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25322874"]}, {"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "KRAS Q61E", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890"]}, {"variant_name": "KRAS Q61P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890", "21575616"]}, {"variant_name": "KRAS Q61R", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G12D", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G13R", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61H", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61L", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA S158L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "TOP1 Amplification", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["24256029"]}, {"variant_name": "TOP1 EXPRESSION", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["19775480"]}, {"variant_name": "TYMS 5' TANDEM REPEAT", "gene_symbol": "TYMS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20628391"]}, {"variant_name": "VEGFA Decreased Peri-therapeutic Expression", "gene_symbol": "VEGFA", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25973082"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["33961795"]}], "error": null}
{"id": "F4.1-000001-P1", "family_id": "F4.1", "template_id": "f4_1_target_validation_gene_disease", "question": "What drugs targeting TOP1 have biomarker evidence in Colorectal Cancer?", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "SLFN11 EXPRESSION", "gene_symbol": "SLFN11", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25089570"]}, {"variant_name": "BRAF D594G", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "BRAF D594K", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF G466V", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["28783719"]}, {"variant_name": "BRAF Mutation", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF V600", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["147167"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024", "19603018"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27729313", "22180495"]}, {"variant_name": "BRAF V600E AND ARAF S490T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND GNAS R201C", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 C121S", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 K57T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "DKK1 NUCLEAR EXPRESSION", "gene_symbol": "DKK1", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25788273"]}, {"variant_name": "KRAS A146P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603018"]}, {"variant_name": "KRAS A146T", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "KRAS Exon 2 Mutation", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25322874"]}, {"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "KRAS Q61E", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890"]}, {"variant_name": "KRAS Q61P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890", "21575616"]}, {"variant_name": "KRAS Q61R", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G12D", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G13R", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61H", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61L", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA S158L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "TOP1 Amplification", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["24256029"]}, {"variant_name": "TOP1 EXPRESSION", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["19775480"]}, {"variant_name": "TYMS 5' TANDEM REPEAT", "gene_symbol": "TYMS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20628391"]}, {"variant_name": "VEGFA Decreased Peri-therapeutic Expression", "gene_symbol": "VEGFA", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25973082"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["33961795"]}], "error": null}
{"id": "F4.1-000001-P2", "family_id": "F4.1", "template_id": "f4_1_target_validation_gene_disease", "question": "List therapies that target TOP1 with evidence in Colorectal Cancer.", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "SLFN11 EXPRESSION", "gene_symbol": "SLFN11", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25089570"]}, {"variant_name": "BRAF D594G", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "BRAF D594K", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF G466V", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["28783719"]}, {"variant_name": "BRAF Mutation", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF V600", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["147167"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024", "19603018"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27729313", "22180495"]}, {"variant_name": "BRAF V600E AND ARAF S490T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND GNAS R201C", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 C121S", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 K57T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "DKK1 NUCLEAR EXPRESSION", "gene_symbol": "DKK1", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25788273"]}, {"variant_name": "KRAS A146P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603018"]}, {"variant_name": "KRAS A146T", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "KRAS Exon 2 Mutation", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25322874"]}, {"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "KRAS Q61E", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890"]}, {"variant_name": "KRAS Q61P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890", "21575616"]}, {"variant_name": "KRAS Q61R", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G12D", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G13R", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61H", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61L", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA S158L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "TOP1 Amplification", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["24256029"]}, {"variant_name": "TOP1 EXPRESSION", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["19775480"]}, {"variant_name": "TYMS 5' TANDEM REPEAT", "gene_symbol": "TYMS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20628391"]}, {"variant_name": "VEGFA Decreased Peri-therapeutic Expression", "gene_symbol": "VEGFA", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25973082"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["33961795"]}], "error": null}
{"id": "F4.1-000001-P3", "family_id": "F4.1", "template_id": "f4_1_target_validation_gene_disease", "question": "Show treatments hitting TOP1 that have biomarker evidence in Colorectal Cancer.", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "SLFN11 EXPRESSION", "gene_symbol": "SLFN11", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25089570"]}, {"variant_name": "BRAF D594G", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "BRAF D594K", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF G466V", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["28783719"]}, {"variant_name": "BRAF Mutation", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF V600", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["147167"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024", "19603018"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27729313", "22180495"]}, {"variant_name": "BRAF V600E AND ARAF S490T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND GNAS R201C", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 C121S", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 K57T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "DKK1 NUCLEAR EXPRESSION", "gene_symbol": "DKK1", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25788273"]}, {"variant_name": "KRAS A146P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603018"]}, {"variant_name": "KRAS A146T", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "KRAS Exon 2 Mutation", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25322874"]}, {"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "KRAS Q61E", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890"]}, {"variant_name": "KRAS Q61P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890", "21575616"]}, {"variant_name": "KRAS Q61R", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G12D", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G13R", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61H", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61L", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA S158L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "TOP1 Amplification", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["24256029"]}, {"variant_name": "TOP1 EXPRESSION", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["19775480"]}, {"variant_name": "TYMS 5' TANDEM REPEAT", "gene_symbol": "TYMS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20628391"]}, {"variant_name": "VEGFA Decreased Peri-therapeutic Expression", "gene_symbol": "VEGFA", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25973082"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["33961795"]}], "error": null}
{"id": "F4.2-000001", "family_id": "F4.2", "template_id": "f4_2_alternative_therapies_from_resistance_genes", "question": "For resistance to Bicalutamide in Prostate Cancer, which therapies target the resistance biomarkers?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Bicalutamide')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Bicalutamide'))\n  OR toLower(t1.name) CONTAINS toLower('Bicalutamide')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'prostate'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Bicalutamide')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "AR", "therapy_name": "Abiraterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["16287438", "24276076", "26030522", "27083183", "27225130"], "ref_urls": ["http://europepmc.org/abstract/MED/16287438", "http://europepmc.org/abstract/MED/24276076", "http://europepmc.org/abstract/MED/26030522", "http://europepmc.org/abstract/MED/27083183", "http://europepmc.org/abstract/MED/27225130"]}, {"gene_symbol": "AR", "therapy_name": "Apalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC", "24002508"], "ref_urls": ["http://europepmc.org/abstract/MED/24002508", "http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC"]}, {"gene_symbol": "AR", "therapy_name": "Cyproterone Acetate", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["12695529", "1838080", "2956461", "2988566", "438696", "6237068", "6260040", "6279337", "6458025", "6771095", "7166160", "7584530"], "ref_urls": ["http://europepmc.org/abstract/MED/12695529", "http://europepmc.org/abstract/MED/1838080", "http://europepmc.org/abstract/MED/2956461", "http://europepmc.org/abstract/MED/2988566", "http://europepmc.org/abstract/MED/438696", "http://europepmc.org/abstract/MED/6237068", "http://europepmc.org/abstract/MED/6260040", "http://europepmc.org/abstract/MED/6279337", "http://europepmc.org/abstract/MED/6458025", "http://europepmc.org/abstract/MED/6771095", "http://europepmc.org/abstract/MED/7166160", "http://europepmc.org/abstract/MED/7584530"]}, {"gene_symbol": "AR", "therapy_name": "Enzalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Expert"], "ref_ids": ["ENZALUTAMIDE"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=ENZALUTAMIDE"]}, {"gene_symbol": "AR", "therapy_name": "Flutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["FDA"], "ref_ids": ["label/2001/18554s23lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf"]}, {"gene_symbol": "AR", "therapy_name": "Galeterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://tokaipharmaceuticals.com/our-programs/about-galeterone/", "23713567", "25591066"], "ref_urls": ["http://europepmc.org/abstract/MED/23713567", "http://europepmc.org/abstract/MED/25591066", "http://tokaipharmaceuticals.com/our-programs/about-galeterone/"]}, {"gene_symbol": "AR", "therapy_name": "Nilutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["DailyMed"], "ref_ids": ["setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"]}, {"gene_symbol": "AR", "therapy_name": "Abiraterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["16287438", "24276076", "26030522", "27083183", "27225130"], "ref_urls": ["http://europepmc.org/abstract/MED/16287438", "http://europepmc.org/abstract/MED/24276076", "http://europepmc.org/abstract/MED/26030522", "http://europepmc.org/abstract/MED/27083183", "http://europepmc.org/abstract/MED/27225130"]}, {"gene_symbol": "AR", "therapy_name": "Apalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC", "24002508"], "ref_urls": ["http://europepmc.org/abstract/MED/24002508", "http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC"]}, {"gene_symbol": "AR", "therapy_name": "Cyproterone Acetate", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["12695529", "1838080", "2956461", "2988566", "438696", "6237068", "6260040", "6279337", "6458025", "6771095", "7166160", "7584530"], "ref_urls": ["http://europepmc.org/abstract/MED/12695529", "http://europepmc.org/abstract/MED/1838080", "http://europepmc.org/abstract/MED/2956461", "http://europepmc.org/abstract/MED/2988566", "http://europepmc.org/abstract/MED/438696", "http://europepmc.org/abstract/MED/6237068", "http://europepmc.org/abstract/MED/6260040", "http://europepmc.org/abstract/MED/6279337", "http://europepmc.org/abstract/MED/6458025", "http://europepmc.org/abstract/MED/6771095", "http://europepmc.org/abstract/MED/7166160", "http://europepmc.org/abstract/MED/7584530"]}, {"gene_symbol": "AR", "therapy_name": "Enzalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Expert"], "ref_ids": ["ENZALUTAMIDE"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=ENZALUTAMIDE"]}, {"gene_symbol": "AR", "therapy_name": "Flutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["FDA"], "ref_ids": ["label/2001/18554s23lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf"]}, {"gene_symbol": "AR", "therapy_name": "Galeterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://tokaipharmaceuticals.com/our-programs/about-galeterone/", "23713567", "25591066"], "ref_urls": ["http://europepmc.org/abstract/MED/23713567", "http://europepmc.org/abstract/MED/25591066", "http://tokaipharmaceuticals.com/our-programs/about-galeterone/"]}, {"gene_symbol": "AR", "therapy_name": "Nilutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["DailyMed"], "ref_ids": ["setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"]}], "error": null}
{"id": "F4.2-000001-P1", "family_id": "F4.2", "template_id": "f4_2_alternative_therapies_from_resistance_genes", "question": "In Prostate Cancer, what therapies target genes causing resistance to Bicalutamide?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Bicalutamide')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Bicalutamide'))\n  OR toLower(t1.name) CONTAINS toLower('Bicalutamide')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'prostate'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Bicalutamide')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "AR", "therapy_name": "Abiraterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["16287438", "24276076", "26030522", "27083183", "27225130"], "ref_urls": ["http://europepmc.org/abstract/MED/16287438", "http://europepmc.org/abstract/MED/24276076", "http://europepmc.org/abstract/MED/26030522", "http://europepmc.org/abstract/MED/27083183", "http://europepmc.org/abstract/MED/27225130"]}, {"gene_symbol": "AR", "therapy_name": "Apalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC", "24002508"], "ref_urls": ["http://europepmc.org/abstract/MED/24002508", "http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC"]}, {"gene_symbol": "AR", "therapy_name": "Cyproterone Acetate", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["12695529", "1838080", "2956461", "2988566", "438696", "6237068", "6260040", "6279337", "6458025", "6771095", "7166160", "7584530"], "ref_urls": ["http://europepmc.org/abstract/MED/12695529", "http://europepmc.org/abstract/MED/1838080", "http://europepmc.org/abstract/MED/2956461", "http://europepmc.org/abstract/MED/2988566", "http://europepmc.org/abstract/MED/438696", "http://europepmc.org/abstract/MED/6237068", "http://europepmc.org/abstract/MED/6260040", "http://europepmc.org/abstract/MED/6279337", "http://europepmc.org/abstract/MED/6458025", "http://europepmc.org/abstract/MED/6771095", "http://europepmc.org/abstract/MED/7166160", "http://europepmc.org/abstract/MED/7584530"]}, {"gene_symbol": "AR", "therapy_name": "Enzalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Expert"], "ref_ids": ["ENZALUTAMIDE"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=ENZALUTAMIDE"]}, {"gene_symbol": "AR", "therapy_name": "Flutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["FDA"], "ref_ids": ["label/2001/18554s23lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf"]}, {"gene_symbol": "AR", "therapy_name": "Galeterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://tokaipharmaceuticals.com/our-programs/about-galeterone/", "23713567", "25591066"], "ref_urls": ["http://europepmc.org/abstract/MED/23713567", "http://europepmc.org/abstract/MED/25591066", "http://tokaipharmaceuticals.com/our-programs/about-galeterone/"]}, {"gene_symbol": "AR", "therapy_name": "Nilutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["DailyMed"], "ref_ids": ["setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"]}, {"gene_symbol": "AR", "therapy_name": "Abiraterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["16287438", "24276076", "26030522", "27083183", "27225130"], "ref_urls": ["http://europepmc.org/abstract/MED/16287438", "http://europepmc.org/abstract/MED/24276076", "http://europepmc.org/abstract/MED/26030522", "http://europepmc.org/abstract/MED/27083183", "http://europepmc.org/abstract/MED/27225130"]}, {"gene_symbol": "AR", "therapy_name": "Apalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC", "24002508"], "ref_urls": ["http://europepmc.org/abstract/MED/24002508", "http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC"]}, {"gene_symbol": "AR", "therapy_name": "Cyproterone Acetate", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["12695529", "1838080", "2956461", "2988566", "438696", "6237068", "6260040", "6279337", "6458025", "6771095", "7166160", "7584530"], "ref_urls": ["http://europepmc.org/abstract/MED/12695529", "http://europepmc.org/abstract/MED/1838080", "http://europepmc.org/abstract/MED/2956461", "http://europepmc.org/abstract/MED/2988566", "http://europepmc.org/abstract/MED/438696", "http://europepmc.org/abstract/MED/6237068", "http://europepmc.org/abstract/MED/6260040", "http://europepmc.org/abstract/MED/6279337", "http://europepmc.org/abstract/MED/6458025", "http://europepmc.org/abstract/MED/6771095", "http://europepmc.org/abstract/MED/7166160", "http://europepmc.org/abstract/MED/7584530"]}, {"gene_symbol": "AR", "therapy_name": "Enzalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Expert"], "ref_ids": ["ENZALUTAMIDE"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=ENZALUTAMIDE"]}, {"gene_symbol": "AR", "therapy_name": "Flutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["FDA"], "ref_ids": ["label/2001/18554s23lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf"]}, {"gene_symbol": "AR", "therapy_name": "Galeterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://tokaipharmaceuticals.com/our-programs/about-galeterone/", "23713567", "25591066"], "ref_urls": ["http://europepmc.org/abstract/MED/23713567", "http://europepmc.org/abstract/MED/25591066", "http://tokaipharmaceuticals.com/our-programs/about-galeterone/"]}, {"gene_symbol": "AR", "therapy_name": "Nilutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["DailyMed"], "ref_ids": ["setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"]}], "error": null}
{"id": "F4.2-000001-P2", "family_id": "F4.2", "template_id": "f4_2_alternative_therapies_from_resistance_genes", "question": "Which drugs target biomarkers of resistance to Bicalutamide in Prostate Cancer?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Bicalutamide')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Bicalutamide'))\n  OR toLower(t1.name) CONTAINS toLower('Bicalutamide')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'prostate'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Bicalutamide')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "AR", "therapy_name": "Abiraterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["16287438", "24276076", "26030522", "27083183", "27225130"], "ref_urls": ["http://europepmc.org/abstract/MED/16287438", "http://europepmc.org/abstract/MED/24276076", "http://europepmc.org/abstract/MED/26030522", "http://europepmc.org/abstract/MED/27083183", "http://europepmc.org/abstract/MED/27225130"]}, {"gene_symbol": "AR", "therapy_name": "Apalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC", "24002508"], "ref_urls": ["http://europepmc.org/abstract/MED/24002508", "http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC"]}, {"gene_symbol": "AR", "therapy_name": "Cyproterone Acetate", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["12695529", "1838080", "2956461", "2988566", "438696", "6237068", "6260040", "6279337", "6458025", "6771095", "7166160", "7584530"], "ref_urls": ["http://europepmc.org/abstract/MED/12695529", "http://europepmc.org/abstract/MED/1838080", "http://europepmc.org/abstract/MED/2956461", "http://europepmc.org/abstract/MED/2988566", "http://europepmc.org/abstract/MED/438696", "http://europepmc.org/abstract/MED/6237068", "http://europepmc.org/abstract/MED/6260040", "http://europepmc.org/abstract/MED/6279337", "http://europepmc.org/abstract/MED/6458025", "http://europepmc.org/abstract/MED/6771095", "http://europepmc.org/abstract/MED/7166160", "http://europepmc.org/abstract/MED/7584530"]}, {"gene_symbol": "AR", "therapy_name": "Enzalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Expert"], "ref_ids": ["ENZALUTAMIDE"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=ENZALUTAMIDE"]}, {"gene_symbol": "AR", "therapy_name": "Flutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["FDA"], "ref_ids": ["label/2001/18554s23lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf"]}, {"gene_symbol": "AR", "therapy_name": "Galeterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://tokaipharmaceuticals.com/our-programs/about-galeterone/", "23713567", "25591066"], "ref_urls": ["http://europepmc.org/abstract/MED/23713567", "http://europepmc.org/abstract/MED/25591066", "http://tokaipharmaceuticals.com/our-programs/about-galeterone/"]}, {"gene_symbol": "AR", "therapy_name": "Nilutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["DailyMed"], "ref_ids": ["setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"]}, {"gene_symbol": "AR", "therapy_name": "Abiraterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["16287438", "24276076", "26030522", "27083183", "27225130"], "ref_urls": ["http://europepmc.org/abstract/MED/16287438", "http://europepmc.org/abstract/MED/24276076", "http://europepmc.org/abstract/MED/26030522", "http://europepmc.org/abstract/MED/27083183", "http://europepmc.org/abstract/MED/27225130"]}, {"gene_symbol": "AR", "therapy_name": "Apalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC", "24002508"], "ref_urls": ["http://europepmc.org/abstract/MED/24002508", "http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC"]}, {"gene_symbol": "AR", "therapy_name": "Cyproterone Acetate", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["12695529", "1838080", "2956461", "2988566", "438696", "6237068", "6260040", "6279337", "6458025", "6771095", "7166160", "7584530"], "ref_urls": ["http://europepmc.org/abstract/MED/12695529", "http://europepmc.org/abstract/MED/1838080", "http://europepmc.org/abstract/MED/2956461", "http://europepmc.org/abstract/MED/2988566", "http://europepmc.org/abstract/MED/438696", "http://europepmc.org/abstract/MED/6237068", "http://europepmc.org/abstract/MED/6260040", "http://europepmc.org/abstract/MED/6279337", "http://europepmc.org/abstract/MED/6458025", "http://europepmc.org/abstract/MED/6771095", "http://europepmc.org/abstract/MED/7166160", "http://europepmc.org/abstract/MED/7584530"]}, {"gene_symbol": "AR", "therapy_name": "Enzalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Expert"], "ref_ids": ["ENZALUTAMIDE"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=ENZALUTAMIDE"]}, {"gene_symbol": "AR", "therapy_name": "Flutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["FDA"], "ref_ids": ["label/2001/18554s23lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf"]}, {"gene_symbol": "AR", "therapy_name": "Galeterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://tokaipharmaceuticals.com/our-programs/about-galeterone/", "23713567", "25591066"], "ref_urls": ["http://europepmc.org/abstract/MED/23713567", "http://europepmc.org/abstract/MED/25591066", "http://tokaipharmaceuticals.com/our-programs/about-galeterone/"]}, {"gene_symbol": "AR", "therapy_name": "Nilutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["DailyMed"], "ref_ids": ["setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"]}], "error": null}
{"id": "F4.2-000001-P3", "family_id": "F4.2", "template_id": "f4_2_alternative_therapies_from_resistance_genes", "question": "Find therapies that target resistance genes for Bicalutamide in Prostate Cancer.", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Bicalutamide')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Bicalutamide'))\n  OR toLower(t1.name) CONTAINS toLower('Bicalutamide')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'prostate'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Bicalutamide')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [{"gene_symbol": "AR", "therapy_name": "Abiraterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["16287438", "24276076", "26030522", "27083183", "27225130"], "ref_urls": ["http://europepmc.org/abstract/MED/16287438", "http://europepmc.org/abstract/MED/24276076", "http://europepmc.org/abstract/MED/26030522", "http://europepmc.org/abstract/MED/27083183", "http://europepmc.org/abstract/MED/27225130"]}, {"gene_symbol": "AR", "therapy_name": "Apalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC", "24002508"], "ref_urls": ["http://europepmc.org/abstract/MED/24002508", "http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC"]}, {"gene_symbol": "AR", "therapy_name": "Cyproterone Acetate", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["12695529", "1838080", "2956461", "2988566", "438696", "6237068", "6260040", "6279337", "6458025", "6771095", "7166160", "7584530"], "ref_urls": ["http://europepmc.org/abstract/MED/12695529", "http://europepmc.org/abstract/MED/1838080", "http://europepmc.org/abstract/MED/2956461", "http://europepmc.org/abstract/MED/2988566", "http://europepmc.org/abstract/MED/438696", "http://europepmc.org/abstract/MED/6237068", "http://europepmc.org/abstract/MED/6260040", "http://europepmc.org/abstract/MED/6279337", "http://europepmc.org/abstract/MED/6458025", "http://europepmc.org/abstract/MED/6771095", "http://europepmc.org/abstract/MED/7166160", "http://europepmc.org/abstract/MED/7584530"]}, {"gene_symbol": "AR", "therapy_name": "Enzalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Expert"], "ref_ids": ["ENZALUTAMIDE"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=ENZALUTAMIDE"]}, {"gene_symbol": "AR", "therapy_name": "Flutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["FDA"], "ref_ids": ["label/2001/18554s23lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf"]}, {"gene_symbol": "AR", "therapy_name": "Galeterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://tokaipharmaceuticals.com/our-programs/about-galeterone/", "23713567", "25591066"], "ref_urls": ["http://europepmc.org/abstract/MED/23713567", "http://europepmc.org/abstract/MED/25591066", "http://tokaipharmaceuticals.com/our-programs/about-galeterone/"]}, {"gene_symbol": "AR", "therapy_name": "Nilutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["DailyMed"], "ref_ids": ["setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"]}, {"gene_symbol": "AR", "therapy_name": "Abiraterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["16287438", "24276076", "26030522", "27083183", "27225130"], "ref_urls": ["http://europepmc.org/abstract/MED/16287438", "http://europepmc.org/abstract/MED/24276076", "http://europepmc.org/abstract/MED/26030522", "http://europepmc.org/abstract/MED/27083183", "http://europepmc.org/abstract/MED/27225130"]}, {"gene_symbol": "AR", "therapy_name": "Apalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC", "24002508"], "ref_urls": ["http://europepmc.org/abstract/MED/24002508", "http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC"]}, {"gene_symbol": "AR", "therapy_name": "Cyproterone Acetate", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["12695529", "1838080", "2956461", "2988566", "438696", "6237068", "6260040", "6279337", "6458025", "6771095", "7166160", "7584530"], "ref_urls": ["http://europepmc.org/abstract/MED/12695529", "http://europepmc.org/abstract/MED/1838080", "http://europepmc.org/abstract/MED/2956461", "http://europepmc.org/abstract/MED/2988566", "http://europepmc.org/abstract/MED/438696", "http://europepmc.org/abstract/MED/6237068", "http://europepmc.org/abstract/MED/6260040", "http://europepmc.org/abstract/MED/6279337", "http://europepmc.org/abstract/MED/6458025", "http://europepmc.org/abstract/MED/6771095", "http://europepmc.org/abstract/MED/7166160", "http://europepmc.org/abstract/MED/7584530"]}, {"gene_symbol": "AR", "therapy_name": "Enzalutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Expert"], "ref_ids": ["ENZALUTAMIDE"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=ENZALUTAMIDE"]}, {"gene_symbol": "AR", "therapy_name": "Flutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["FDA"], "ref_ids": ["label/2001/18554s23lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf"]}, {"gene_symbol": "AR", "therapy_name": "Galeterone", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://tokaipharmaceuticals.com/our-programs/about-galeterone/", "23713567", "25591066"], "ref_urls": ["http://europepmc.org/abstract/MED/23713567", "http://europepmc.org/abstract/MED/25591066", "http://tokaipharmaceuticals.com/our-programs/about-galeterone/"]}, {"gene_symbol": "AR", "therapy_name": "Nilutamide", "targets_moa": "Androgen Receptor antagonist", "ref_sources": ["DailyMed"], "ref_ids": ["setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7"]}], "error": null}
{"id": "F5.1-000001", "family_id": "F5.1", "template_id": "f5_1_biomarkers_in_disease", "question": "In Scrotum Paget's Disease, which biomarkers have evidence?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'scrotum' AND\n    toLower(rel.disease_name) CONTAINS 'paget\\'s' AND\n    toLower(rel.disease_name) CONTAINS 'disease'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab", "effect": "sensitivity", "disease_name": "Scrotum Paget's Disease", "pmids": ["25692060"]}], "error": null}
{"id": "F5.1-000001-P1", "family_id": "F5.1", "template_id": "f5_1_biomarkers_in_disease", "question": "Which biomarkers show evidence in Scrotum Paget's Disease?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'scrotum' AND\n    toLower(rel.disease_name) CONTAINS 'paget\\'s' AND\n    toLower(rel.disease_name) CONTAINS 'disease'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab", "effect": "sensitivity", "disease_name": "Scrotum Paget's Disease", "pmids": ["25692060"]}], "error": null}
{"id": "F5.1-000001-P2", "family_id": "F5.1", "template_id": "f5_1_biomarkers_in_disease", "question": "List biomarkers with AFFECTS evidence in Scrotum Paget's Disease.", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'scrotum' AND\n    toLower(rel.disease_name) CONTAINS 'paget\\'s' AND\n    toLower(rel.disease_name) CONTAINS 'disease'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab", "effect": "sensitivity", "disease_name": "Scrotum Paget's Disease", "pmids": ["25692060"]}], "error": null}
{"id": "F5.1-000001-P3", "family_id": "F5.1", "template_id": "f5_1_biomarkers_in_disease", "question": "What biomarkers have therapy response evidence in Scrotum Paget's Disease?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'scrotum' AND\n    toLower(rel.disease_name) CONTAINS 'paget\\'s' AND\n    toLower(rel.disease_name) CONTAINS 'disease'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab", "effect": "sensitivity", "disease_name": "Scrotum Paget's Disease", "pmids": ["25692060"]}], "error": null}
{"id": "F5.2-000001", "family_id": "F5.2", "template_id": "f5_2_therapies_with_biomarker_evidence_in_disease", "question": "List therapies with variant-level biomarkers in Ovarian Clear Cell Carcinoma.", "cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'clear' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "MET Overexpression", "gene_symbol": "MET", "therapy_name": "Cabozantinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["29061793"]}, {"variant_name": "ARID1A Loss", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["27364904"]}, {"variant_name": "ARID1A Loss OR ARID1A Wildtype", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["37418832"]}, {"variant_name": "ARID1A P1175FS*5", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["27364904"]}, {"variant_name": "ARID1A Loss", "gene_symbol": "ARID1A", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["25686104"]}], "error": null}
{"id": "F5.2-000001-P1", "family_id": "F5.2", "template_id": "f5_2_therapies_with_biomarker_evidence_in_disease", "question": "Which therapies have variant biomarkers in Ovarian Clear Cell Carcinoma?", "cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'clear' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "MET Overexpression", "gene_symbol": "MET", "therapy_name": "Cabozantinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["29061793"]}, {"variant_name": "ARID1A Loss", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["27364904"]}, {"variant_name": "ARID1A Loss OR ARID1A Wildtype", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["37418832"]}, {"variant_name": "ARID1A P1175FS*5", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["27364904"]}, {"variant_name": "ARID1A Loss", "gene_symbol": "ARID1A", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["25686104"]}], "error": null}
{"id": "F5.2-000001-P2", "family_id": "F5.2", "template_id": "f5_2_therapies_with_biomarker_evidence_in_disease", "question": "Show drugs with variant-based evidence in Ovarian Clear Cell Carcinoma.", "cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'clear' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "MET Overexpression", "gene_symbol": "MET", "therapy_name": "Cabozantinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["29061793"]}, {"variant_name": "ARID1A Loss", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["27364904"]}, {"variant_name": "ARID1A Loss OR ARID1A Wildtype", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["37418832"]}, {"variant_name": "ARID1A P1175FS*5", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["27364904"]}, {"variant_name": "ARID1A Loss", "gene_symbol": "ARID1A", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["25686104"]}], "error": null}
{"id": "F5.2-000001-P3", "family_id": "F5.2", "template_id": "f5_2_therapies_with_biomarker_evidence_in_disease", "question": "List treatments supported by variant evidence in Ovarian Clear Cell Carcinoma.", "cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'clear' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "MET Overexpression", "gene_symbol": "MET", "therapy_name": "Cabozantinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["29061793"]}, {"variant_name": "ARID1A Loss", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["27364904"]}, {"variant_name": "ARID1A Loss OR ARID1A Wildtype", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["37418832"]}, {"variant_name": "ARID1A P1175FS*5", "gene_symbol": "ARID1A", "therapy_name": "Dasatinib", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["27364904"]}, {"variant_name": "ARID1A Loss", "gene_symbol": "ARID1A", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Ovarian Clear Cell Carcinoma", "pmids": ["25686104"]}], "error": null}
{"id": "F6.1-000001", "family_id": "F6.1", "template_id": "f6_1_resistance_genes_for_union_therapies_in_disease", "question": "Which genes predict resistance to Savolitinib or Dabrafenib in Lung Non-small Cell Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Savolitinib')\n  OR toLower(t.name) = toLower('Dabrafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Savolitinib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dabrafenib'))\n  OR toLower(t.name) CONTAINS toLower('Savolitinib')\n  OR toLower(t.name) CONTAINS toLower('Dabrafenib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23524406"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Savolitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27694386"]}], "error": null}
{"id": "F6.1-000001-P1", "family_id": "F6.1", "template_id": "f6_1_resistance_genes_for_union_therapies_in_disease", "question": "In Lung Non-small Cell Carcinoma, which genes confer resistance to Savolitinib or Dabrafenib?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Savolitinib')\n  OR toLower(t.name) = toLower('Dabrafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Savolitinib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dabrafenib'))\n  OR toLower(t.name) CONTAINS toLower('Savolitinib')\n  OR toLower(t.name) CONTAINS toLower('Dabrafenib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23524406"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Savolitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27694386"]}], "error": null}
{"id": "F6.1-000001-P2", "family_id": "F6.1", "template_id": "f6_1_resistance_genes_for_union_therapies_in_disease", "question": "List resistance genes for Savolitinib or Dabrafenib in Lung Non-small Cell Carcinoma.", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Savolitinib')\n  OR toLower(t.name) = toLower('Dabrafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Savolitinib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dabrafenib'))\n  OR toLower(t.name) CONTAINS toLower('Savolitinib')\n  OR toLower(t.name) CONTAINS toLower('Dabrafenib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23524406"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Savolitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27694386"]}], "error": null}
{"id": "F6.1-000001-P3", "family_id": "F6.1", "template_id": "f6_1_resistance_genes_for_union_therapies_in_disease", "question": "What genes are resistance biomarkers for Savolitinib or Dabrafenib in Lung Non-small Cell Carcinoma?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Savolitinib')\n  OR toLower(t.name) = toLower('Dabrafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Savolitinib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dabrafenib'))\n  OR toLower(t.name) CONTAINS toLower('Savolitinib')\n  OR toLower(t.name) CONTAINS toLower('Dabrafenib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n", "result": [{"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23524406"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Savolitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27694386"]}], "error": null}
{"id": "F6.2-000001", "family_id": "F6.2", "template_id": "f6_2_therapies_target_gene_not_other_with_disease_evidence", "question": "What therapies target TOP1 but NOT ALK, and have biomarker evidence in Colorectal Cancer?", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('ALK')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "SLFN11 EXPRESSION", "gene_symbol": "SLFN11", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25089570"]}, {"variant_name": "BRAF D594G", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "BRAF D594K", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF G466V", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["28783719"]}, {"variant_name": "BRAF Mutation", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF V600", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["147167"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024", "19603018"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27729313", "22180495"]}, {"variant_name": "BRAF V600E AND ARAF S490T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND GNAS R201C", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 C121S", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 K57T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "DKK1 NUCLEAR EXPRESSION", "gene_symbol": "DKK1", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25788273"]}, {"variant_name": "KRAS A146P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603018"]}, {"variant_name": "KRAS A146T", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "KRAS Exon 2 Mutation", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25322874"]}, {"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "KRAS Q61E", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890"]}, {"variant_name": "KRAS Q61P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890", "21575616"]}, {"variant_name": "KRAS Q61R", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G12D", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G13R", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61H", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61L", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA S158L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "TOP1 Amplification", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["24256029"]}, {"variant_name": "TOP1 EXPRESSION", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["19775480"]}, {"variant_name": "TYMS 5' TANDEM REPEAT", "gene_symbol": "TYMS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20628391"]}, {"variant_name": "VEGFA Decreased Peri-therapeutic Expression", "gene_symbol": "VEGFA", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25973082"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["33961795"]}], "error": null}
{"id": "F6.2-000001-P1", "family_id": "F6.2", "template_id": "f6_2_therapies_target_gene_not_other_with_disease_evidence", "question": "Which drugs hit TOP1 but not ALK with evidence in Colorectal Cancer?", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('ALK')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "SLFN11 EXPRESSION", "gene_symbol": "SLFN11", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25089570"]}, {"variant_name": "BRAF D594G", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "BRAF D594K", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF G466V", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["28783719"]}, {"variant_name": "BRAF Mutation", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF V600", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["147167"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024", "19603018"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27729313", "22180495"]}, {"variant_name": "BRAF V600E AND ARAF S490T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND GNAS R201C", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 C121S", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 K57T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "DKK1 NUCLEAR EXPRESSION", "gene_symbol": "DKK1", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25788273"]}, {"variant_name": "KRAS A146P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603018"]}, {"variant_name": "KRAS A146T", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "KRAS Exon 2 Mutation", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25322874"]}, {"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "KRAS Q61E", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890"]}, {"variant_name": "KRAS Q61P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890", "21575616"]}, {"variant_name": "KRAS Q61R", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G12D", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G13R", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61H", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61L", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA S158L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "TOP1 Amplification", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["24256029"]}, {"variant_name": "TOP1 EXPRESSION", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["19775480"]}, {"variant_name": "TYMS 5' TANDEM REPEAT", "gene_symbol": "TYMS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20628391"]}, {"variant_name": "VEGFA Decreased Peri-therapeutic Expression", "gene_symbol": "VEGFA", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25973082"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["33961795"]}], "error": null}
{"id": "F6.2-000001-P2", "family_id": "F6.2", "template_id": "f6_2_therapies_target_gene_not_other_with_disease_evidence", "question": "List therapies targeting TOP1 (not ALK) with evidence in Colorectal Cancer.", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('ALK')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "SLFN11 EXPRESSION", "gene_symbol": "SLFN11", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25089570"]}, {"variant_name": "BRAF D594G", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "BRAF D594K", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF G466V", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["28783719"]}, {"variant_name": "BRAF Mutation", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF V600", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["147167"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024", "19603018"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27729313", "22180495"]}, {"variant_name": "BRAF V600E AND ARAF S490T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND GNAS R201C", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 C121S", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 K57T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "DKK1 NUCLEAR EXPRESSION", "gene_symbol": "DKK1", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25788273"]}, {"variant_name": "KRAS A146P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603018"]}, {"variant_name": "KRAS A146T", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "KRAS Exon 2 Mutation", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25322874"]}, {"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "KRAS Q61E", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890"]}, {"variant_name": "KRAS Q61P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890", "21575616"]}, {"variant_name": "KRAS Q61R", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G12D", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G13R", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61H", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61L", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA S158L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "TOP1 Amplification", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["24256029"]}, {"variant_name": "TOP1 EXPRESSION", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["19775480"]}, {"variant_name": "TYMS 5' TANDEM REPEAT", "gene_symbol": "TYMS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20628391"]}, {"variant_name": "VEGFA Decreased Peri-therapeutic Expression", "gene_symbol": "VEGFA", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25973082"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["33961795"]}], "error": null}
{"id": "F6.2-000001-P3", "family_id": "F6.2", "template_id": "f6_2_therapies_target_gene_not_other_with_disease_evidence", "question": "Show treatments for TOP1 excluding ALK that have biomarker evidence in Colorectal Cancer.", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('ALK')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "SLFN11 EXPRESSION", "gene_symbol": "SLFN11", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25089570"]}, {"variant_name": "BRAF D594G", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "BRAF D594K", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF G466V", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["28783719"]}, {"variant_name": "BRAF Mutation", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "BRAF V600", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["147167"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024", "19603018"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["27729313", "22180495"]}, {"variant_name": "BRAF V600E AND ARAF S490T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND GNAS R201C", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 C121S", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "BRAF V600E AND MAP2K1 K57T", "gene_symbol": "BRAF", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["27729313"]}, {"variant_name": "DKK1 NUCLEAR EXPRESSION", "gene_symbol": "DKK1", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["25788273"]}, {"variant_name": "KRAS A146P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603018"]}, {"variant_name": "KRAS A146T", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["26989027"]}, {"variant_name": "KRAS Exon 2 Mutation", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25322874"]}, {"variant_name": "KRAS G12/G13", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "KRAS Q61E", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890"]}, {"variant_name": "KRAS Q61P", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20570890", "21575616"]}, {"variant_name": "KRAS Q61R", "gene_symbol": "KRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G12D", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS G13R", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61H", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "NRAS Q61L", "gene_symbol": "NRAS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA E545Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["19603024"]}, {"variant_name": "PIK3CA Q546K", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA R88Q", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "PIK3CA S158L", "gene_symbol": "PIK3CA", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20619739"]}, {"variant_name": "TOP1 Amplification", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["24256029"]}, {"variant_name": "TOP1 EXPRESSION", "gene_symbol": "TOP1", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["19775480"]}, {"variant_name": "TYMS 5' TANDEM REPEAT", "gene_symbol": "TYMS", "therapy_name": "Irinotecan", "effect": "resistance", "disease_name": "Colorectal Cancer", "pmids": ["20628391"]}, {"variant_name": "VEGFA Decreased Peri-therapeutic Expression", "gene_symbol": "VEGFA", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["25973082"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab Deruxtecan", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["33961795"]}], "error": null}
{"id": "F6.3-000001", "family_id": "F6.3", "template_id": "f6_3_therapies_target_gene_with_variant_resistance_in_disease", "question": "Find therapies that target EGFR for variants that cause resistance in Lung Non-small Cell Carcinoma.", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('EGFR')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('EGFR'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24035188"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Dacomitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21430269"]}, {"variant_name": "EGFR A767_V769dupASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR A859T", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR D770_N771insNPG", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D770_N771insSVD", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160", "17877814"]}, {"variant_name": "EGFR H773_V774insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR M766_A767insAI", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR N771delinsGY", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR N826S", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19147750"]}, {"variant_name": "EGFR P772_H773insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P772_H773insYNP", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P848L", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR S768N", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19786660", "21132006"]}, {"variant_name": "EGFR S784F", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21841502"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25668228", "27304188", "15737014", "21132006"]}, {"variant_name": "EGFR V769_D770insASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR Y764_V765insHH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15728811", "17020982", "15737014"]}, {"variant_name": "EGFR Wildtype", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19692680"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18408761"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Naquotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25939061"]}, {"variant_name": "EGFR M766Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31254668"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Rociletinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}], "error": null}
{"id": "F6.3-000001-P1", "family_id": "F6.3", "template_id": "f6_3_therapies_target_gene_with_variant_resistance_in_disease", "question": "Which therapies targeting EGFR have variant-level resistance in Lung Non-small Cell Carcinoma?", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('EGFR')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('EGFR'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24035188"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Dacomitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21430269"]}, {"variant_name": "EGFR A767_V769dupASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR A859T", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR D770_N771insNPG", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D770_N771insSVD", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160", "17877814"]}, {"variant_name": "EGFR H773_V774insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR M766_A767insAI", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR N771delinsGY", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR N826S", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19147750"]}, {"variant_name": "EGFR P772_H773insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P772_H773insYNP", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P848L", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR S768N", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19786660", "21132006"]}, {"variant_name": "EGFR S784F", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21841502"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25668228", "27304188", "15737014", "21132006"]}, {"variant_name": "EGFR V769_D770insASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR Y764_V765insHH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15728811", "17020982", "15737014"]}, {"variant_name": "EGFR Wildtype", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19692680"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18408761"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Naquotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25939061"]}, {"variant_name": "EGFR M766Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31254668"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Rociletinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}], "error": null}
{"id": "F6.3-000001-P2", "family_id": "F6.3", "template_id": "f6_3_therapies_target_gene_with_variant_resistance_in_disease", "question": "List drugs targeting EGFR with resistant variants in Lung Non-small Cell Carcinoma.", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('EGFR')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('EGFR'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24035188"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Dacomitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21430269"]}, {"variant_name": "EGFR A767_V769dupASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR A859T", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR D770_N771insNPG", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D770_N771insSVD", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160", "17877814"]}, {"variant_name": "EGFR H773_V774insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR M766_A767insAI", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR N771delinsGY", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR N826S", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19147750"]}, {"variant_name": "EGFR P772_H773insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P772_H773insYNP", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P848L", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR S768N", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19786660", "21132006"]}, {"variant_name": "EGFR S784F", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21841502"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25668228", "27304188", "15737014", "21132006"]}, {"variant_name": "EGFR V769_D770insASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR Y764_V765insHH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15728811", "17020982", "15737014"]}, {"variant_name": "EGFR Wildtype", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19692680"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18408761"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Naquotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25939061"]}, {"variant_name": "EGFR M766Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31254668"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Rociletinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}], "error": null}
{"id": "F6.3-000001-P3", "family_id": "F6.3", "template_id": "f6_3_therapies_target_gene_with_variant_resistance_in_disease", "question": "Show therapies for EGFR where variants cause resistance in Lung Non-small Cell Carcinoma.", "cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('EGFR')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('EGFR'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "result": [{"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24035188"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Dacomitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21430269"]}, {"variant_name": "EGFR A767_V769dupASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR A859T", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR D770_N771insNPG", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D770_N771insSVD", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160", "17877814"]}, {"variant_name": "EGFR H773_V774insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR M766_A767insAI", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR N771delinsGY", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006"]}, {"variant_name": "EGFR N826S", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19147750"]}, {"variant_name": "EGFR P772_H773insH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P772_H773insYNP", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR P848L", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17877814"]}, {"variant_name": "EGFR S768N", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19786660", "21132006"]}, {"variant_name": "EGFR S784F", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21841502"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25668228", "27304188", "15737014", "21132006"]}, {"variant_name": "EGFR V769_D770insASV", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR Y764_V765insHH", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24353160"]}, {"variant_name": "EGFR D761Y", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["17085664"]}, {"variant_name": "EGFR Mutation", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25948633"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15728811", "17020982", "15737014"]}, {"variant_name": "EGFR Wildtype", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["19692680"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18408761"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Naquotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25939061"]}, {"variant_name": "EGFR M766Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31254668"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Rociletinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}], "error": null}
{"id": "F6.4-000001", "family_id": "F6.4", "template_id": "f6_4_alternative_therapies_for_resistance_in_disease", "question": "For resistance to Palbociclib in Ovarian Cancer, which therapies target the resistance biomarkers?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Palbociclib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Palbociclib'))\n  OR toLower(t1.name) CONTAINS toLower('Palbociclib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Palbociclib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [], "error": null}
{"id": "F6.4-000001-P1", "family_id": "F6.4", "template_id": "f6_4_alternative_therapies_for_resistance_in_disease", "question": "In Ovarian Cancer, what therapies target genes linked to resistance to Palbociclib?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Palbociclib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Palbociclib'))\n  OR toLower(t1.name) CONTAINS toLower('Palbociclib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Palbociclib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [], "error": null}
{"id": "F6.4-000001-P2", "family_id": "F6.4", "template_id": "f6_4_alternative_therapies_for_resistance_in_disease", "question": "Which treatments target resistance biomarkers for Palbociclib in Ovarian Cancer?", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Palbociclib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Palbociclib'))\n  OR toLower(t1.name) CONTAINS toLower('Palbociclib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Palbociclib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [], "error": null}
{"id": "F6.4-000001-P3", "family_id": "F6.4", "template_id": "f6_4_alternative_therapies_for_resistance_in_disease", "question": "Find alternative therapies targeting resistance genes for Palbociclib in Ovarian Cancer.", "cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Palbociclib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Palbociclib'))\n  OR toLower(t1.name) CONTAINS toLower('Palbociclib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Palbociclib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n", "result": [], "error": null}
